Lorbas, “An expansion phase of the study was
Post# of 148169
(Total Views: 544)
Posted On: 08/28/2020 5:53:07 PM
Lorbas,
“An expansion phase of the study was added to enroll up to 5,600 additional patients, including those on mechanical ventilation.“
I’m still working on Gilead’s or FDA’s or Big Pharm’s cock-blocking of Leronlimab. But this kinda tells me what’s going on.
Big Pharma can quickly enroll a 5,600 expansion. And go from SOC to M/M to block our great M/M results.
I’m still confused how “including those on mechanical ventilation” has anything to with Mild to Moderate.
I’m still not selling one share of Cytodyn. Gilead could win Covid. I’m here for much more. Including multiples of 3.44.
“An expansion phase of the study was added to enroll up to 5,600 additional patients, including those on mechanical ventilation.“
I’m still working on Gilead’s or FDA’s or Big Pharm’s cock-blocking of Leronlimab. But this kinda tells me what’s going on.
Big Pharma can quickly enroll a 5,600 expansion. And go from SOC to M/M to block our great M/M results.
I’m still confused how “including those on mechanical ventilation” has anything to with Mild to Moderate.
I’m still not selling one share of Cytodyn. Gilead could win Covid. I’m here for much more. Including multiples of 3.44.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼